Palbociclib and Letrozole in Advanced Breast Cancer
Work
Year: 2016
Type: article
Abstract: A phase 2 study showed that progression-free survival was longer with palbociclib plus letrozole than with letrozole alone in the initial treatment of postmenopausal women with estrogen-receptor (ER)–... more
Source: New England Journal of Medicine
Institutions University of California, Los Angeles, Hospital General Universitario Gregorio Marañón, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Seoul National University Hospital +5 more
Cites: 12
Cited by: 2,383
Related to: 10
FWCI: 167.2
Citation percentile (by year/subfield): 100
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze